Search Within

Ying Zhang Mazzu

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (4)
  2. Meeting Abstract (1)
Groups
  1. Department of Medicine (5)
  2. GSK Faculty (5)
  3. Genitourinary Oncology Service (5)
  4. Human Oncology and Pathogenesis Program (5)
  5. Sloan Kettering Institute Postdocs (5)
  6. Solid Tumor Oncology Division (5)

More Groups

People
  1. Goutam Chakraborty (5)
  2. Philip Kantoff (5)
  3. Subhiksha Nandakumar (5)
  4. Lina Jehane (4)
  5. Nikolaus Schultz (3)
  6. Rahim Hirani (3)

More People

Years
  1. 2022 (2)
  2. 2021 (1)
  3. 2020 (2)
Publications
  1. Clinical Cancer Research (2)
  2. Cancer Research (1)
  3. Molecular Oncology (1)
  4. Oncogene (1)
Publishers
  1. American Association for Cancer Research (3)
  2. FEBS Press (1)
  3. Nature Publishing Group (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The impact of PIK3R1 mutations and insulin-PI3K-glycolytic pathway regulation in prostate cancer
    Journal Article

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Nguyen, B.; Stopsack, K. H.; Kreitzer, C.; Rajanala, S. H.; Ghale, R.; Mazzu, Y. Z.; Pillarsetty, N. V. K.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Prognostic and therapeutic significance of COP9 signalosome subunit CSN5 in prostate cancer
    Journal Article

    Mazzu, Y. Z.; Liao, Y. R.; Nandakumar, S.; Jehane, L. E.; Koche, R. P.; Rajanala, S. H.; Li, R.; Zhao, H. Y.; Gerke, T. A.; Chakraborty, G.; more...
    Oncogene (2022)

    Fulltext@MSK | Save
  • Identification and characterization of the PIK3R1-mutant subtype in PI3K-addicted prostate cancer
    Meeting Abstract

    Chakraborty, G.; Nandakumar, S.; Hirani, R.; Rajanala, S. H.; Nguyen, B.; Ghale, R.; Mazzu, Y. Z.; Jehane, L. E.; Lee, G. S. M.; Mucci, L. A.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Ribonucleotide reductase small subunit M2 is a master driver of aggressive prostate cancer
    Journal Article

    Mazzu, Y. Z.; Armenia, J.; Nandakumar, S.; Chakraborty, G.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; Atiq, M.; Khan, N.; Schultz, N.; more...
    Molecular Oncology (2020)

    Fulltext@MSK | Save
  • Significance of BRCA2 and RB1 co-loss in aggressive prostate cancer progression
    Journal Article

    Chakraborty, G.; Armenia, J.; Mazzu, Y. Z.; Nandakumar, S.; Stopsack, K. H.; Atiq, M. O.; Komura, K.; Jehane, L.; Hirani, R.; Chadalavada, K.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save